2070.SR
2070.SR
SA0007879188
Saudi Pharmaceutical Industries
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.706.711.000 1.682.000.000
1.5%
Cost of Revenue 874.157.000 844.970.000
3.5%
Gross Profit 832.554.000 837.030.000
0.5%
584.680.000 679.321.000
13.9%
Operating Income 247.874.000 157.709.000
57.2%
Pretax Income 205.650.000 72.009.000
185.6%
Net Income Common Stockholders 184.363.000 24.535.000
651.4%
-- --
--
-- --
--
ende